Screener
Aquestive Therapeutics, Inc. AQST Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 4:08 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001398733-26-000030
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Property and equipment, net | 3,839 | 3,893 |
| Right-of-use assets, net | 4,468 | 4,621 |
| Other non-current assets | 2,635 | 2,642 |
| Total assets | $141,125 | $160,425 |
| Liabilities and stockholders’ deficit | ||
| Current liabilities: | ||
| Accounts payable | $11,889 | $29,862 |
| Accrued expenses | 3,449 | 5,029 |
Item 1. FINANCIAL STATEMENTS (Unaudited)
FAQ
- What is Aquestive Therapeutics, Inc.'s total assets?
- Aquestive Therapeutics, Inc. (AQST) reported total assets of $141.13M in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s total assets changed year-over-year?
- Aquestive Therapeutics, Inc.'s total assets increased by 38.0% year-over-year, from $102.23M to $141.13M.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s total assets?
- Over 5 years (2020 to 2025), Aquestive Therapeutics, Inc.'s total assets has grown at a 20.6% compound annual growth rate (CAGR), from $62.88M to $160.43M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Aquestive Therapeutics, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude